Skip to content
★ Sign in to follow
BB

Benjamin Bulkley

Invitrogen CorpVeradigm Inc.
Total declarations
18
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€5.0M

Latest filing published 14 Oct 2008 for Veradigm Inc., €670k.

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

No signal scores available.

Benjamin Bulkley: trading record in brief

Benjamin Bulkley has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Invitrogen Corp and Veradigm Inc. Over a trading history stretching from 14 February 2007 to 19 September 2008, the count stands at 18 filings.

On the market, this insider has only sold: 7 sales, €5.0M in total. Other entries cover 4 share grants and 6 option exercises. So far in 2008, the count stands at no purchases and 1 sale.

Most recently, on 14 October 2008, the filings show a transaction worth €670k in Veradigm Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Benjamin Bulkley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ●
    Chief Operating OfficerExecutivesVeradigm Inc.
    965,718 USD0SEC
    74,286 shares@ US$13.00Common StockSEC:0001181431-08-057219:0
  • ▼
    Chief Operating OfficerExecutivesVeradigm Inc.
    107,289 USD0SEC
    8,253 shares@ US$13.00Common StockSEC:0001181431-08-057219:1
  • ◆
    Chief Operating OfficerExecutivesVeradigm Inc.
    30,186 USD0SEC
    2,306 shares@ US$13.09Common StockSEC:0001181431-08-052460:0
  • ◆
    Chief Operating OfficerExecutivesVeradigm Inc.
    0SEC
    49,900 shares0Common StockSEC:0001181431-08-006054:0
  • ◆
    Chief Operating OfficerExecutivesVeradigm Inc.
    0SEC
    21,598 shares0Common StockSEC:0001181431-07-061536:0
  • ◆
    Chief Operating OfficerExecutivesVeradigm Inc.
    0SEC
    21,922 shares0Common StockSEC:0001181431-07-045097:0
  • ◇
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    324,969 USD0SEC
    5,323 shares@ US$61.05Common StockSEC:0001266260-07-000002:0
  • ▼
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    352,010 USD0SEC
    5,323 shares@ US$66.13Common StockSEC:0001266260-07-000002:1
  • ◇
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    3M USD0SEC
    45,000 shares@ US$61.05Common StockSEC:0001266260-07-000002:2
  • ▼
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    3M USD0SEC
    45,000 shares@ US$66.13Common StockSEC:0001266260-07-000002:3
  • ◇
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    2M USD0SEC
    30,926 shares@ US$61.05Common StockSEC:0001266260-07-000002:4
  • ▼
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    2M USD0SEC
    30,926 shares@ US$66.20Common StockSEC:0001266260-07-000002:5
  • ◇
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    490,350 USD0SEC
    7,500 shares@ US$65.38Common StockSEC:0001266260-07-000002:6
  • ▼
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    496,500 USD0SEC
    7,500 shares@ US$66.20Common StockSEC:0001266260-07-000002:7
  • ◇
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    406,315 USD0SEC
    6,500 shares@ US$62.51Common StockSEC:0001266260-07-000002:8
  • ▼
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    430,300 USD0SEC
    6,500 shares@ US$66.20Common StockSEC:0001266260-07-000002:9
  • ◇
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    201,594 USD0SEC
    3,125 shares@ US$64.51Common StockSEC:0001266260-07-000002:10
  • ▼
    Sr. VP Global Commercial OpsExecutivesInvitrogen Corp
    206,875 USD0SEC
    3,125 shares@ US$66.20Common StockSEC:0001266260-07-000002:11

18 of 18 declarations